Note : Learn how retinol serums and creams differ to choose the appropriate formulation
The main ongoing studies: REDEFINE 1 , Phase 3 obesity without T2D (results 20242025, preliminarily 25.3 %) REDEFINE 2 , Phase 3 obesity + T2D REDEFINE 3 , Phase 3 cardiovascular outcome trial (n~7000) Stand-alone clinical development of Cagrilintide is limited , Novo Nordisk is primarily investing in the CagriSema combination
Interestingly, in the PREvencin con DIeta MEDiterrnea-Plus (Predimed-Plus) trial in overweight or obese individuals with metabolic syndrome, an increase in dietary choline intake over a one-year period was associated with improved measures of cardiovascular health (i.e., lower serum total cholesterol, serum LDL cholesterol, and systolic and diastolic blood pressure levels) (123)
Proprietary Blend: 280 mg
Carvalho GC, Sbio RM, De Cssia RT, Monteiro AS, Pereira DV, Ribeiro SJL, et al